Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

SODIUM PHOSPHATES IN PLASTIC CONTAINER

SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Standard Dose
4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview SODIUM PHOSPHATES IN PLASTIC CONTAINER is listed in Drugs@FDA under application 018892 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Form and strength SOLUTION;INTRAVENOUS - 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) Sponsor HOSPIRA Submission history Latest submission status date: 2023-11-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM PHOSPHATES IN PLASTIC CONTAINER is listed in Drugs@FDA under application 018892 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Form and strength SOLUTION;INTRAVENOUS - 4.02GM/15ML;4.14GM/15ML (268MG/ML;276MG/ML) Sponsor HOSPIRA Submission history Latest submission status date: 2023-11-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.